Skip to main content

BMC Pharmacology and Toxicology

New Content Item

Collection: Hepatitis C

The 2020 Nobel Prize for Physiology or Medicine was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of Hepatitis C virus. In celebration of what they started and showcasing areas of research that have since emerged, we here present a collection of articles from the BMC Biology, BMC Medicine, Genome Medicine and the BMC Series Journals on biology, diagnosis and treatment and wider public health and medical outcomes of the Hepatitis C virus and its infection.

BMC Series Focus Issues

New Content Item

October: Focus on Stem Cells

With Stem Cell Awareness day on the 13th October this year we have compiled an article collection from across different BMC Series journals covering aspects of basic stem cell biology; in vitro differentiation studies; stem-cell based therapy studies for various conditions in animal models; technical advancements and ethical issues. 

Healthcare professionals engaging with authors

September: Patient and public involvement in research

In recognition of World Patient Safety Awareness day on 17th September, the BMC Series presents a focus issue on Patient and Public Involvement (PPI) in research.  We have collated free-to-read content from across our journals - showcasing patient perspectives, research into the study of PPI, and engaging public partners as co-authors in research.

Featured articles

New Content Item

Adverse drug reactions in children

Can we use the Adverse Drug Event Report database for drug safety surveillance in Children? This study on the Japanese database evaluates. 

New Content Item

Can Statin combat antipsychotics-induced weight gain?

In this study in young rats, the authors test the efficacy of statin interventions and particularly, Simvastatin, in reversing second generation antipsychotics-induced dyslipidemia.

Articles

Most recent articles RSS

View all articles

Most accessed articles RSS

View all articles

Aims and scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.

Peer Review Taxonomy

This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.

The following summary describes the peer review process for this journal:

  • Identity transparency: Single anonymized
  • Reviewer interacts with: Editor
  • Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.

Editor

Anne Menard, BioMed Central, UK
 

Assistant Editor

Catriona Leslie, BioMed Central, UK

Data support service

Authors submitting to this journal can opt to use a new service that will make it easier to share research data.

Find out more

BMC Series Blog

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Submit manuscript

Follow

Annual Journal Metrics

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us